Subscribe Sign In

Why register?

Home
News
Events
- Find an event
- Live event coverage
Deep Dive
Sales and marketing
Digital
Market Access
Oncology
Patients
R&D
Spotlight On
- Frontiers Health 2021
- The Future of Generics
Advertise

Search

Search

Close

Trending

Novartis reports two liver-related deaths with Zolgensma

New horizons in breast cancer care

Why reshoring drug production means embracing continuous manufacturing

Clariness, DailyBreath partner to drive recruitment in asthma trials

J&J says it will stop selling all talc products next year

NF1

AstraZeneca/ Merck Inc/ News/ News/ News/ Oncology/ R&D/ Rare diseases/ Top stories/ UK & Europe

Neurofibromatosis treatment granted orphan status by EMA

Piotr Wnuk ASCO 2018, AstraZeneca, ema, genetic, Merck & Co, Neurofibromatosis, NF1, Oncology, Selumetinib 0 Comment

AstraZeneca and Merck & Co. announced the European Medicines Agency (EMA) has granted orphan designation to their codeveloped

X

Neurofibromatosis treatment granted orphan status by EMA

https://pharmaphorum.com/news/nf1-treatment-granted-orphan-status-ema/

Get in-depth news, opinions and features on pharma and healthcare sent straight to your inbox

Featured content

How to improve payer engagement with tailored value communication

How to improve payer engagement with tailored value communication

How will NICE fare in a post-Brexit world?

How will NICE fare in a post-Brexit world?

Events

MAPS 2018 EMEA Annual Meeting

MAPS 2018 EMEA Annual Meeting

Cell & Gene Therapy 2018

Cell & Gene Therapy 2018

Patient Engagement Event - a real world snapshot, beyond the talk

Patient Engagement Event - a real world snapshot, beyond the talk

Most popular

Most Viewed

Dismay as UK 'drags its heels' on AZ's COVID antibody Evusheld
J&J says it will stop selling all talc products next year
Clariness, DailyBreath partner to drive recruitment in asthma trials
Cumulus' gamified dry EEG system tops lab monitoring in trial
Novartis reports two liver-related deaths with Zolgensma

Tweets from @pharmaphorum

Tweets by @pharmaphorum

Advertise
pharmaphorum connect

Contribute
Work for pharmaphorum

About us
Contact us
Privacy policy
Terms & conditions
Cookie Policy

The rights of trade mark owners are acknowledged. pharmaphorum media limited

Website and content copyright © 2009-, pharmaphorum media limited or its licensors; all rights reserved.

© 2022

Powered by WordPress • Themify WordPress Themes

Login

Username or Email Address

Password

Remember Me

Lost your password?

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com